162 related articles for article (PubMed ID: 38383591)
1. The cycad genotoxin methylazoxymethanol, linked to Guam ALS/PDC, induces transcriptional mutagenesis.
Verheijen BM; Chung C; Thompson B; Kim H; Nakahara A; Anink JJ; Mills JD; ; Lee JH; Aronica E; Oyanagi K; Kakita A; Gout JF; Vermulst M
Acta Neuropathol Commun; 2024 Feb; 12(1):30. PubMed ID: 38383591
[No Abstract] [Full Text] [Related]
2. Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?
Kisby GE; Spencer PS
Int J Environ Res Public Health; 2011 Oct; 8(10):3889-921. PubMed ID: 22073019
[TBL] [Abstract][Full Text] [Related]
3. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity.
Esclaire F; Kisby G; Spencer P; Milne J; Lesort M; Hugon J
Exp Neurol; 1999 Jan; 155(1):11-21. PubMed ID: 9918700
[TBL] [Abstract][Full Text] [Related]
4. Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and α-Synuclein, as Reported in ALS-PDC.
Kisby GE; Eriksen JL; Chlebowski AC; Spencer PS
J Neuropathol Exp Neurol; 2021 Feb; 80(3):286-288. PubMed ID: 33550390
[No Abstract] [Full Text] [Related]
5. Parkinsonism and motor neuron disorders: Lessons from Western Pacific ALS/PDC.
Spencer PS
J Neurol Sci; 2022 Feb; 433():120021. PubMed ID: 34635325
[TBL] [Abstract][Full Text] [Related]
6. Guam ALS-PDC: possible causes.
Spencer PS; Kisby GE; Ross SM; Roy DN; Hugon J; Ludolph AC; Nunn PB
Science; 1993 Nov; 262(5135):825-6. PubMed ID: 8235599
[No Abstract] [Full Text] [Related]
7. Western Pacific ALS-PDC: Evidence implicating cycad genotoxins.
Spencer PS; Palmer VS; Kisby GE
J Neurol Sci; 2020 Dec; 419():117185. PubMed ID: 33190068
[TBL] [Abstract][Full Text] [Related]
8. Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?
Kisby G; Palmer V; Lasarev M; Fry R; Iordanov M; Magun E; Samson L; Spencer P
Commun Integr Biol; 2011 Nov; 4(6):731-4. PubMed ID: 22446540
[TBL] [Abstract][Full Text] [Related]
9. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Spencer PS; Palmer V; Kisby G
Neurology; 2009 Feb; 72(5):474-6; author reply 475-6. PubMed ID: 19195086
[No Abstract] [Full Text] [Related]
10. Guamanian ALS: hereditary or acquired?
Kurland LT; Molgaard CA
Adv Neurol; 1982; 36():165-71. PubMed ID: 7180682
[No Abstract] [Full Text] [Related]
11. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Ince PG; Codd GA
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
[TBL] [Abstract][Full Text] [Related]
12. Etiology of Retinal and Cerebellar Pathology in Western Pacific Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex.
Spencer PS
Eye Brain; 2020; 12():97-104. PubMed ID: 32765151
[TBL] [Abstract][Full Text] [Related]
13. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex.
Dombroski BA; Galasko DR; Mata IF; Zabetian CP; Craig UK; Garruto RM; Oyanagi K; Schellenberg GD
JAMA Neurol; 2013 Jun; 70(6):742-5. PubMed ID: 23588498
[TBL] [Abstract][Full Text] [Related]
14. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam.
Poorkaj P; Tsuang D; Wijsman E; Steinbart E; Garruto RM; Craig UK; Chapman NH; Anderson L; Bird TD; Plato CC; Perl DP; Weiderholt W; Galasko D; Schellenberg GD
Arch Neurol; 2001 Nov; 58(11):1871-8. PubMed ID: 11708997
[TBL] [Abstract][Full Text] [Related]
15. Cycad toxin-induced damage of rodent and human pancreatic beta-cells.
Eizirik DL; Kisby GE
Biochem Pharmacol; 1995 Jul; 50(3):355-65. PubMed ID: 7646537
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update.
Oyanagi K; Wada M
J Neurol; 1999 Sep; 246 Suppl 2():II19-27. PubMed ID: 10525999
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Oyanagi K; Makifuchi T; Ohtoh T; Chen KM; Gajdusek DC; Chase TN
J Neuropathol Exp Neurol; 1997 Mar; 56(3):308-16. PubMed ID: 9056545
[TBL] [Abstract][Full Text] [Related]
18. MGMT, a risk factor for both genetic and environmental forms of dementia.
Kisby GE; Oakes H; Beckett D; Spencer PS
Alzheimers Dement; 2023 May; 19(5):2208-2210. PubMed ID: 36583449
[TBL] [Abstract][Full Text] [Related]
19. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
[TBL] [Abstract][Full Text] [Related]
20. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
Cox PA; Banack S; Murch S; Sacks O
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):679-82. PubMed ID: 17083482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
